ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Nanotechnology start-up Liquidia Technologies has raised $7 million in a third round of venture capital financing, led by Canaan Partners. Liquidia has developed a polymer technology to create micro- and nanoparticles for drug delivery. The company plans to use the funds to advance its first product, a vaccine, into Phase I clinical studies in late 2010. It will also invest in manufacturing clinical supplies of the drug.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X